Cover Image
Market Research Report

Asia Pacific Proteomics Market Forecast 2019-2027

Published by Inkwood Research Product code 823176
Published Content info 110 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Proteomics Market Forecast 2019-2027
Published: April 15, 2019 Content info: 110 Pages
Description

KEY FINDINGS

Proteomics can explain questions that were unsolved by genomics, as proteins are the functional unit of cells. The Asia Pacific proteomics is estimated to grow from $XX billion in 2018 to $XX billion by 2027, at a CAGR of 16.54% between 2019 and 2027. Japan dominated the overall market in terms of revenue in 2018 and Japan is expected to be the fastest growing market over the forecast period in the APAC proteomics market.

MARKET INSIGHTS

The Asia-Pacific provides several lucrative opportunities for the expansion of the proteomics market, owing to the rise in demand for drug discovery and advances in the biotechnology sector. The proteomics market witnessed rapid development in recent years.

The economies of China, India, Japan, South Korea, Australia and the Rest of Asia Pacific are the major contributors by revenue to the regional market for proteomics in APAC. Japan is had dominated the global scenario in 2018 significantly because of the growing life sciences research infrastructure in the country that is fast-tracking its market growth.

COMPETITIVE INSIGHTS

Waters Corporation, Bio-Rad Laboratories, Inc., LI-COR Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Horiba, Ltd., Qiagen N.V., General Electric Company, Bruker Corporation, Merck & Company Inc., Caprion Biosciences (acquired by GHO Capital), GlaxoSmithKline, Luminex Corp., Agilent Technologies, Inc., and PerkinElmer, Inc. are the eminent market players which are mentioned in the report.

Table of Contents
Product Code: 24606

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. REAGENTS ARE THE WIDELY USED PROTEOMICS COMPONENT
    • 3.2.2. DISEASE DIAGNOSIS IS THE FASTEST GROWING APPLICATION
    • 3.2.3. DRUG DISCOVERY AND DEVELOPMENT IS THE MAJORLY USED END-USER

4. MARKET DETERMINANTS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. ADVANCEMENT IN PROTEOMIC TECHNOLOGIES
    • 4.2.2. INCREASE IN R&D EXPENDITURE
    • 4.2.3. TECHNOLOGICAL ADVANCEMENTS
    • 4.2.4. INCREASING USE OF PROTEOMICS INFORMATION
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST OF INSTRUMENTS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. IDENTIFICATION OF NOVEL BIOMARKERS
    • 4.4.2. WIDESPREAD USE OF MASS SPECTROMETER TO STUDY PROTEIN-PROTEIN INTERACTION
  • 4.5. MARKET CHALLENGES
    • 4.5.1. LACK OF SKILLED PROFESSIONALS
    • 4.5.2. STRINGENT REGULATIONS

5. MARKET BY APPLICATION

  • 5.1. DRUG DISCOVERY
  • 5.2. DISEASE DIAGNOSIS
  • 5.3. OTHER APPLICATION

6. MARKET BY COMPONENT

  • 6.1. REAGENTS
  • 6.2. INSTRUMENTS
  • 6.3. SERVICES

7. KEY ANALYTICS

  • 7.1. PORTER'S FIVE FORCES MODEL
    • 7.1.1. THREAT OF NEW ENTRANTS
    • 7.1.2. THREAT OF SUBSTITUTE
    • 7.1.3. BARGAINING POWER OF BUYERS
    • 7.1.4. BARGAINING POWER OF SUPPLIERS
    • 7.1.5. THREAT OF COMPETITIVE RIVALRY
  • 7.2. PROTEOMICS INDUSTRY ANALYSIS
  • 7.3. APPLICATIONS OF PROTEOMIC IN DRUG DISCOVERY AND DEVELOPMENT
  • 7.4. SCIENTIFIC INITIATIVES IN PROTEOMICS
  • 7.5. PATENT ANALYSIS
  • 7.6. OPPORTUNITY MATRIX

8. GEOGRAPHICAL ANALYSIS

  • 8.1. ASIA PACIFIC
    • 8.1.1. JAPAN
    • 8.1.2. CHINA
    • 8.1.3. INDIA
    • 8.1.4. AUSTRALIA
    • 8.1.5. SOUTH KOREA
    • 8.1.6. REST OF ASIA-PACIFIC

9. COMPETITIVE LANDSCAPE

  • 9.1. MARKET POSITION ANALYSIS
  • 9.2. COMPANY PROFILES
    • 9.2.1. AGILENT TECHNOLOGIES, INC.
    • 9.2.2. BIO-RAD LABORATORIES, INC.
    • 9.2.3. BRUKER CORPORATION
    • 9.2.4. CAPRION BIOSCIENCES (ACQUIRED BY GHO CAPITAL)
    • 9.2.5. DANAHER CORPORATION
    • 9.2.6. GENERAL ELECTRIC COMPANY
    • 9.2.7. GLAXOSMITHKLINE
    • 9.2.8. HORIBA, LTD.
    • 9.2.9. LI-COR INC.
    • 9.2.10. LUMINEX CORP.
    • 9.2.11. MERCK & COMPANY INC.
    • 9.2.12. PERKINELMER, INC.
    • 9.2.13. QIAGEN N.V.
    • 9.2.14. THERMO FISHER SCIENTIFIC INC.
    • 9.2.15. WATERS CORPORATION

TABLES LIST

  • TABLE 1 ASIA PACIFIC PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • TABLE 2 ASIA PACIFIC PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 3 ASIA PACIFIC DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)
  • TABLE 4 ASIA PACIFIC DISEASE DIAGNOSIS MARKET 2019-2027 ($ MILLION)
  • TABLE 5 ASIA PACIFIC OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
  • TABLE 6 ASIA PACIFIC PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 7 ASIA PACIFIC REAGENTS MARKET 2019-2027 ($ MILLION)
  • TABLE 8 ASIA PACIFIC INSTRUMENTS MARKET 2019-2027 ($ MILLION)
  • TABLE 9 GENERAL WORKFLOW OF MASS SPECTROMETRY (MS)
  • TABLE 10 ASIA PACIFIC SERVICES MARKET 2019-2027 ($ MILLION)
  • TABLE 11 STATUS OF THE MAJOR PROTEOMICS INDUSTRIES
  • TABLE 12 ARRAY-RELATED PROTEOMICS PATENTS 2015-2018 (%)
  • TABLE 13 LOC-RELATED PROTEOMICS PATENTS 2015-2018 (%)
  • TABLE 14 MASS SPECTROMETRY-RELATED PROTEOMICS PATENTS 2015-2018(%)
  • TABLE 15 ASIA PACIFIC PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 16 JAPAN PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 17 JAPAN PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 18 CHINA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 19 CHINA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 20 INDIA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 21 INDIA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 22 AUSTRALIA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 23 AUSTRALIA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 24 SOUTH KOREA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 25 SOUTH KOREA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 26 PROTEOMICS COMPANY MARKET POSITION ANALYSIS 2017

FIGURES LIST

  • FIGURE 1 ASIA PACIFIC PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 ASIA PACIFIC PROTEOMICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 3 ASIA PACIFIC PROTEOMICS MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)
  • FIGURE 4 ASIA PACIFIC PROTEOMICS MARKET BY DISEASE DIAGNOSIS 2019-2027 ($ MILLION)
  • FIGURE 5 ASIA PACIFIC PROTEOMICS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
  • FIGURE 6 ASIA PACIFIC PROTEOMICS MARKET SHARE BY COMPONENT 2018 & 2027 (%)
  • FIGURE 7 ASIA PACIFIC PROTEOMICS MARKET BY REAGENTS 2019-2027 ($ MILLION)
  • FIGURE 8 ASIA PACIFIC PROTEOMICS MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)
  • FIGURE 9 ASIA PACIFIC PROTEOMICS MARKET BY SERVICES 2019-2027 ($ MILLION)
  • FIGURE 10 PORTER'S FIVE FORCE MODEL
  • FIGURE 11 JAPAN PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 12 CHINA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 13 INDIA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 14 AUSTRALIA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 15 SOUTH KOREA PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 16 REST OF ASIA-PACIFIC PROTEOMICS MARKET 2019-2027 ($ MILLION)
Back to Top